Microbiology Technology, Equipment and Consumables Global Market Report 2025

The microbiology technology, equipment, and consumables market size has grown rapidly in recent years. It will grow from $6.92 billion in 2024 to $7.73 billion in 2025 at a compound annual growth rate (CAGR) of 11.8%. The growth during the historic period can be attributed to the rising prevalence of infectious diseases, increasing demand for clinical diagnostics, wider adoption of molecular biology techniques, expansion of research and development activities in biotechnology and pharmaceuticals, and increased funding for academic and scientific research.

The microbiology technology, equipment, and consumables market size is expected to see rapid growth in the next few years. It will grow to $11.91 billion in 2029 at a compound annual growth rate (CAGR) of 11.4%. The growth in the forecast period can be attributed to the increasing demand for personalized medicine, rising adoption of point-of-care testing, expansion of biopharmaceutical manufacturing, growing investments in life sciences research, and a stronger focus on food safety and environmental monitoring. Key trends in this period include advancements in automation and robotics, innovations in microfluidics and lab-on-a-chip technologies, developments in next-generation sequencing, increased integration of artificial intelligence in microbiology research, and expanding R&D in rapid pathogen detection systems.

The increasing rates of hospital-acquired infections are expected to drive the growth of the microbiology technology, equipment, and consumables market. Hospital-acquired infections occur when patients develop infections during their stay in healthcare facilities that were not present at admission. The rise in these infections is linked to invasive procedures and medical devices that increase patient exposure to pathogens. Microbiology technologies, equipment, and consumables play a critical role in mitigating these infections by enabling rapid detection, monitoring, and control of infectious pathogens, reducing their spread within healthcare settings. For example, in June 2025, the Australian Institute of Health and Welfare reported that out of approximately 12.6 million hospital admissions in 2023-24, around 150,000 involved at least one hospital-acquired complication. The incidence rate of such complications was 1.9 per 100 admissions in public hospitals and 0.8 per 100 admissions in private hospitals.

Companies in the market are focusing on automation innovations to improve laboratory workflows and efficiency. One such advancement is custom and flexible robotic track configurations, which allow modular automation systems to be tailored to a laboratory’s workflow and layout, connecting multiple instruments for scalable, end-to-end microbiology processes. In January 2023, Becton, Dickinson and Company introduced its third-generation BD Kiestra Total Lab Automation System for microbiology laboratories. The system enhances testing quality and consistency while reducing turnaround times, allowing labs to manage increasing sample volumes efficiently. By automating both routine and complex workflows, it addresses workforce shortages and improves operational efficiency, offering a cost-effective solution that boosts productivity and accuracy in modern clinical microbiology diagnostics.

In January 2023, Haier Biomedical Co. Ltd., a China-based life science company, acquired Suzhou Kangsheng Biotechnology Co. Ltd. The acquisition allows Haier Biomedical to integrate Suzhou Kangsheng’s expertise in laboratory consumables, strengthening its smart laboratory solutions and expanding applications in microbiology, cell culture, and related life science fields. Suzhou Kangsheng specializes in microbiology technology, equipment, and consumables.

Major players in the microbiology technology, equipment and consumables market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, 3M Company, MERCK KGaA, Danaher Corporation, Becton, Dickinson and Company, Quest Diagnostics Inc., Agilent Technologies Inc., Illumina Inc., bioMérieux Inc., Sartorius AG, Shimadzu Corporation, Sysmex Corporation, Greiner Bio-One International GmbH, Promega Corporation, Oxford Nanopore Technologies Plc, Hardy Diagnostics Co., Copan Diagnostics Inc., Zymo Research Corporation, HiMedia Laboratories Private Limited, and Kuhner AG.

North America was the largest region in the microbiology technology, equipment, and consumables market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in microbiology technology, equipment, and consumables report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the pharmaceutical companies contend with tariffs on APIs, glass vials, and lab equipment inputs with few alternative sources. Generic drug makers, operating on razor-thin margins, are especially vulnerable, with some reducing production of low-profit medicines. Biotech firms face delays in clinical trials due to tariff-related shortages of specialized reagents. In response, the industry is expanding API production in India and Europe, increasing inventory stockpiles, and pushing for trade exemptions for essential medicines.

The microbiology technology, equipment, and consumables market research report is one of a series of new reports that provides microbiology technology, equipment, and consumables market statistics, including the microbiology technology, equipment, and consumables industry global market size, regional shares, competitors with the microbiology technology, equipment, and consumables market share, detailed microbiology technology, equipment, and consumables market segments, market trends, and opportunities, and any further data you may need to thrive in the microbiology technology, equipment, and consumables industry. This microbiology technology, equipment, and consumables market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

Microbiology technology, equipment, and consumables refer to the specialized instruments, tools, and materials used to study and analyze microorganisms such as bacteria, fungi, viruses, and protozoa. This field leverages advanced laboratory systems and essential supplies to detect, cultivate, and examine microbial entities with accuracy and reliability.

The main product categories include instruments, consumables, and services. Instruments are laboratory devices designed to perform microbiological analyses and experiments efficiently and precisely. They are employed across various test types, including bacterial, viral, fungal, and parasitic analyses, and utilize technologies ranging from conventional microbiology to molecular methods, immunology-based techniques, and automated or digital systems. These products find applications in clinical diagnostics, food and beverage testing, pharmaceutical and biotechnology research, environmental monitoring, and agricultural or industrial testing. Key end-users include hospitals and diagnostic laboratories, pharmaceutical and biotechnology companies, food and beverage manufacturers, academic and research institutions, and environmental or agricultural testing facilities.

The countries covered in the microbiology technology, equipment, and consumables market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The microbiology technology, equipment, and consumables market consists of revenues earned by entities by providing services such as laboratory testing services, microbiological analysis services, equipment calibration and maintenance, and research and development support. The market value includes the value of related goods sold by the service provider or included within the service offering. The microbiology technology, equipment, and consumables market also includes sales of pipettes, centrifuges, biosafety cabinets, laboratory refrigerators, test tubes, flasks, reagents, lab consumables, and microbial identification kits. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.